Pharma/Biotech – USA, Europe, Asia and ROW Regulatory News – June 2024


Posted July 24, 2024 by kevin2020

Stay informed with the latest regulatory news in Pharma and Biotech for June 2024, covering the USA, Europe, Asia, and the rest of the world. Key updates include FDA authorizations, EMA recommendations.

 
The U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert Xpress System, the first hepatitis C virus (HCV) test that can be used to bring diagnosis to appropriately certified point-of-care settings for individuals at risk for hepatitis C. The test may be performed in settings operating under a CLIA (Clinical Laboratory Improvement Amendments) Certificate of Waiver, such as certain substance use disorder treatment facilities, correctional facilities, syringe service programs, doctor’s offices, emergency departments and urgent care clinics.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By vistaar.ai
Phone +44 20 3936 5437
Business Address 9-3-3223 near church,California
Country United States
Categories Health , Medical , Services
Tags biotech updates , clinical trials , drug safety , healthcare regulations , medical devices
Last Updated July 24, 2024